评估来自Leishmania spp.的MHC I类结合. 为开发针对内脏莱什曼病的疫苗

André Luiz Zaidan1, Ana Laura Grossi de Oliveira1, Ramayana Morais de Medeiros Brito2

  • 1Laboratory of Immunobiology and Control of Parasites, Postgraduate Program in Parasitology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil; Postgraduate Program in Health Sciences, School of Medicine, Federal University of Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil.

Vaccine
|July 24, 2025
PubMed
概括

研究人员确定了激发免疫反应的关键leishmania寄生虫. 两种主导对开发针对内脏莱什曼病 (VL) 的新疫苗有前途.